Financial Publications
Marinomed’s financial publications (reports, presentations etc.) are listed below in chronological order and are available to download in PDF format.
Bericht des Vorstands der Marinomed Biotech AG FN 276819 m, ISIN ATMARINOMED6 gemäß § 174 Abs 4 iVm § 153 Abs 4, § 171 Abs 1 AktG (German Only)
Investor Presentation H1 2021
Half-Year Financial Report 2021
Conference Call Invitation - Half-Year Results 2021
Update Q1 2021
Investor Presentation Q1 2021
Conference Call Invitation - Results Q1 2021
Jahresfinanzbericht 2020 (ESEF)
Investor Presentation - Results FY 2020
Annual Report 2020
Financial Report 2020
Conference Call Invitation - Full year results 2020
Update Q3 2020
Investor Presentation Q3
Conference Call Invitation - Results Q3 2020
Investor Presentation H1 2020
Half-Year Financial Report 2020
Conference Call Invitation - Results H1 2020
Investor Presentation SARS-CoV-2
Update Q1 2020
Investor Presentation Q1 2020
Conference Call Invitation - Results Q1 2020
Investor Presentation - Results FY 2019
Financial Report 2019
Annual Report 2019
Investor Presentation Q3 2019
Update Q3 2019
Investor Presentation H1 2019
Half-Year Financial Report 2019
Half-Year Financial Report 2019 incl. UGB
Update Q1 2019
Investors Update 2018
Veröffentlichung gemäß § 5 Abs. 2 Rechnungslegungs-Kontrollgesetz (RL-KG) vom 04.09.2020 (German only)
Financial Report 2018
Annual Report 2018
Annual Report 2017
Audit report (German language only)